About Sanozen Pharma Private Limited
Data last updated:
Sanozen Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2016PTC110123. Its GSTIN is 36AAXCS1592D1ZX (Telangana).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.4 Lakh. It is led by directors Vijayaprakash Katikala and Manikya Swarna Latha Kodali.
Its last annual general meeting (AGM) was held on 12 June 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No. 65 Doyens Township Serilingampally Gachibowli To Bhel Road, Hyderabad, Telangana, India – 500019.
As per the financials filed for FY 2023, the company reported a revenue of ₹61.2 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹9.74 Lakh (net margin -15.9%) and EBITDA of ₹54,882 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 17% over five years.
As per MCA filings, the company has open charges of ₹35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanozenpharma.com.
Company details
Contact details
Sanozen Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is sanozenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 65 Doyens Township Serilingampally Gachibowli To Bhel Road, Hyderabad, Telangana, India – 500019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanozen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sanozen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanozen Pharma Private Limited, buy the company report.
Financials of Sanozen Pharma Private Limited
FY 2023 filings availableSanozen Pharma Private Limited reported revenue of ₹61.2 Lakh (down 3% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹61.2 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54,882 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -15.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanozen Pharma Private Limited, buy the company report.
Board of directors of Sanozen Pharma Private Limited
Sanozen Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijayaprakash Katikala Also directs: SPPT Chem Private Limited, SP Accure Labs Private Limited | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Manikya Swarna Latha Kodali Also directs: SPPT Chem Private Limited, SP Accure Labs Private Limited | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
Auditor
Sanozen Pharma Private Limited is audited by RAVI MANDULA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI MANDULA & ASSOCIATES | FY 2023 | 016558S |
Shareholding
The shareholding of Sanozen Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanozen Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Apr 2025 | 101087644 | Others | ₹10 Cr | Open | |
| 25 May 2023 | 100737865 | Yes Bank Limited | ₹25 Cr | Open |
To see the full charge records of Sanozen Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sanozen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanozen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sanozen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAXCS1592D1ZX | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanozen Pharma Private Limited, buy the company report.
Recent activity
Sanozen Pharma Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Sanjeeva Reddy Jagavarappu ceased to be Director on 24 Jul 2023.
Frequently asked questions
Sanozen Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 June 2016 (10+ years old) and is registered under CIN U24239TG2016PTC110123.
Sanozen Pharma has 2 current directors:
- Vijayaprakash Katikala - Director
- Manikya Swarna Latha Kodali - Director
The latest financial statements of Sanozen Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 12 June 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sanozen Pharma is 36AAXCS1592D1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Sanozen Pharma is U24239TG2016PTC110123. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanozen Pharma was incorporated on 06 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sanjeeva Reddy Jagavarappu ceased to be Director on 24 Jul 2023. Manikya Swarna Latha Kodali was appointed as Director on 12 Jun 2023. Vijayaprakash Katikala was appointed as Director on 12 Jun 2023. Sanozen Pharma has 6 board changes on record in total.
Sanozen Pharma can be reached through the website sanozenpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Sanozen Pharma is at Plot No. 65 Doyens Township Serilingampally Gachibowli To Bhel Road, Hyderabad, Telangana, India – 500019.
Sanozen Pharma operates in the pharma industry, in the drug formulation and development segment.